Small Molecules

Orally dissolving tablets could be a good match for patients that dislike swallowing tablets.

Why the pharma community should pay more attention to plants and other natural sources of new compounds.

What does your product demand guesstimate look like, and how can you be sure things won’t suddenly change?

Could donated skin be a viable alternative to animal testing?

Nine years ago we set out to characterize and evaluate our raw materials - this is what we found out…

Today's small molecules are increasingly complex, but generic producers must keep track of trends

Could electrochemistry give drug discovery and manufacturing a boost?

Raymond Sackler, philanthropist, psychopharmacology pioneer, and former CEO of Purdue Pharma, dies aged 97.

Each new drug is unique and deserves a fresh approach to formulation.

Can enzyme immobilization enhance biocatalysis further?